Bioplus Acquisition Corp (BIOS) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bioplus Acquisition Corp   (NASDAQ: BIOS)


Bioplus Acquisition's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bioplus Acquisition's ROI in the second quarter of 2023?
Bioplus Acquisition Corp achieved a return on average invested assets (ROI) of 2.72 % in its second quarter of 2023 a new company high.

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2023.

Within the Healthcare sector 170 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2023 quarter, so far to 1876, from total ROI ranking in the first quarter of 2023 at 1979.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM 22.93 % 108.02 % 327.66 % - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 137 240 238 236 236
Return On Investment (TTM) 2.72 % 1.93 % 0.84 % 0.18 % -0.14 %
BIOS's Overall Ranking # 1876 # 1979 # 2468 # 0 # 0
Seq. Investment Change TTM -10.42 % 0.48 % 1.81 % 34.13 % 51.6 %
Seq. Net Income Change TTM 26.55 % 129.42 % 373.72 % - -
Net Income (TTM) in Millions 6 5 2 0 0

BIOS Company Profile >> Back to BIOS Roi Comparisons >> See Annual BIOS Return On Investment



Return On Investment BIOS's Ranking
Within: No.
Industry # 54
Sector # 171
Overall # 1876

Return On Investment Statistics
High Average Low
2.72 %
1.26 %
-0.44 %
(Jun 30 2023)  







Financial Statements
Bioplus Acquisition's II. Quarter Investments $ 137 Millions BIOS's Balance sheet
Bioplus Acquisition's II. Quarter Income $ 1 Millions Quarterly BIOS's Income Statement
BIOS's Income by Division See BIOS's Income by Division


BIOS Annual Return On Investment (Dec 31 2022)
2022



Total Investments in Millions 238 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 2 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 0.84 % - - - -


Annual Roi Comment
In the fiscal year 2022 ROI deteriorated to 0.84 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BIOS's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BIOS's Competitors
Subscribers only: Roi for Bioplus Acquisition's Suppliers
Subscribers only: Return On Investment for BIOS's Customers

Other Ratios
BIOS's Roa BIOS's Inventory Turnover Ratio BIOS's Growth Rates BIOS's Dividend Statistics
BIOS's Profitability Ratios BIOS's Asset Turnover Ratio BIOS's Dividend Growth
BIOS's Roe BIOS's Valuation Ratios BIOS's Financial Strength Ratios BIOS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI
Maravai Lifesciences Holdings Inc   7.32 %
Charles River Laboratories International inc   7.21 %
Viemed Healthcare Inc   7.06 %
Lftd Partners Inc   6.97 %
Fonar Corporation  6.81 %
Alkermes Plc   6.79 %
Staar Surgical Co  6.71 %
Addus Homecare Corp  6.68 %
Redwoods Acquisition Corp  6.45 %
Universal Health Services Inc   6.13 %
Embecta Corp   6.09 %
Moderna Inc   6.07 %
Hologic Inc  6.01 %
Merit Medical Systems Inc  5.90 %
Teleflex Incorporated  5.86 %
Acadia Healthcare Company Inc   5.82 %
Horizon Therapeutics Public Limited Company  5.71 %
Iqvia Holdings Inc   5.66 %
Kewaunee Scientific Corporation  5.61 %
Lifevantage Corp  5.58 %
Repligen Corp  5.47 %
Ensign Group Inc  5.27 %
Privia Health Group Inc   5.23 %
Sensus Healthcare Inc   4.99 %
U S Physical Therapy Inc  4.74 %
Northview Acquisition Corp  4.71 %
Labcorp Holdings Inc   4.70 %
Davita Inc   4.68 %
Masimo Corp  4.62 %
Third Harmonic Bio Inc   4.61 %

Date modified: 2026-06-22T16:30:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.